三九医药推出新股改方案
９月(yue)２日(ri)，三(san)(san)九医药股(gu)(gu)(gu)(gu)份(fen)(fen)有限公(gong)(gong)司(si)公(gong)(gong)布(bu)了调整(zheng)后的股(gu)(gu)(gu)(gu)改方(fang)案(an)。根(gen)据新(xin)方(fang)案(an)，三(san)(san)九医药流通股(gu)(gu)(gu)(gu)股(gu)(gu)(gu)(gu)东(dong)每１０股(gu)(gu)(gu)(gu)将获送３股(gu)(gu)(gu)(gu)股(gu)(gu)(gu)(gu)份(fen)(fen)，如果三(san)(san)九医药２００８年(nian)度基本每股(gu)(gu)(gu)(gu)收(shou)益(yi)低于(yu)(yu)０．５０元或２００９年(nian)度基本每股(gu)(gu)(gu)(gu)收(shou)益(yi)低于(yu)(yu)０．６５元，则将再获得追(zhui)送０．３股(gu)(gu)(gu)(gu)。新(xin)方(fang)案(an)中(zhong)，三(san)(san)九医药控(kong)股(gu)(gu)(gu)(gu)股(gu)(gu)(gu)(gu)东(dong)新(xin)三(san)(san)九控(kong)股(gu)(gu)(gu)(gu)还(hai)承诺，上市(shi)公(gong)(gong)司(si)收(shou)购(gou)完成后，其所持(chi)有的非流通股(gu)(gu)(gu)(gu)股(gu)(gu)(gu)(gu)份(fen)(fen)自公(gong)(gong)司(si)股(gu)(gu)(gu)(gu)权(quan)分置(zhi)改革方(fang)案(an)实施后首(shou)个交(jiao)易(yi)日(ri)起，６０个月(yue)内不(bu)通过深交(jiao)所上市(shi)交(jiao)易(yi)。
据悉，三(san)九(jiu)医药在７月９日公布了“资本公积(ji)金定向转增(zeng)＋送(song)股(gu)＋认购权(quan)利和(he)认沽权(quan)利”的(de)三(san)合一股(gu)改方案，折合成(cheng)送(song)股(gu)模(mo)型(xing)相(xiang)当于(yu)１０送(song)２．９股(gu)。由于(yu)股(gu)改方案较为(wei)复杂，结合流通(tong)股(gu)股(gu)东(dong)尤(you)其是中小流通(tong)股(gu)股(gu)东(dong)的(de)要求，三(san)九(jiu)医药重新推(tui)出了以“简(jian)单”送(song)股(gu)为(wei)主要内(nei)容的(de)新股(gu)改方案。
返回顶部
